Filing search / Current reports / Taysha Gene Therapies, Inc. / Page 3

8-K

hotxosv78r

9 Sep 22

Regulation FD Disclosure

4:55pm

8-K

b4rls6lvv

11 Aug 22

Taysha Gene Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update

7:17am

8-K

w28g4axv

21 Jun 22

Submission of Matters to a Vote of Security Holders

4:01pm

8-K

qi30s6b2zynoj6z9v

16 May 22

Taysha Gene Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update

7:05am

8-K

hfkhx

31 Mar 22

Taysha Gene Therapies Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Corporate Update

7:15am

8-K

vgpweya

31 Jan 22

Other Events

7:16am

8-K

65t7frzhj689cq

27 Jan 22

Other Events

7:15am

8-K

9purqt0b

10 Nov 21

Taysha Gene Therapies Reports Third Quarter 2021 Financial Results and Provides Corporate Update

7:29am

8-K

kzaboim1yy

5 Oct 21

CLN7 program currently in Phase 1 clinical proof-of-concept trial with preliminary data anticipated by year-end 2021

7:15am

8-K

cqi1sml 0z0r6nu9f7p

16 Aug 21

Taysha Gene Therapies Reports Second Quarter 2021 Financial Results and Provides Corporate Update

7:16am

8-K

ba5zugd

29 Jun 21

Regulation FD Disclosure

7:30am

8-K

psexl4i

28 Jun 21

Regulation FD Disclosure

7:33am

8-K

stpr9vl1f4wqcr

17 Jun 21

Submission of Matters to a Vote of Security Holders

5:12pm

8-K

s9r4ny7

11 May 21

Taysha Gene Therapies Reports First Quarter 2021 Financial Results and Provides a Corporate Update

7:15am

8-K

7luuezt

14 Apr 21

Regulation FD Disclosure

4:20pm

8-K

711 b5rgdc

12 Apr 21

Taysha Gene Therapies Acquires Exclusive Worldwide Rights to Clinical-Stage AAV9 Gene Therapy

7:15am

8-K

r4jpc992q 91lfw

9 Mar 21

Taysha to have an exclusive option on new payloads, constructs, and intellectual property arising from research conducted under the agreement

7:32am

8-K/A

kqzkxsyje2ncgl2ar8p

5 Mar 21

Taysha Gene Therapies Reports Third Quarter 2020 Financial Results and Provides Business Update

4:30pm

8-K

ef1e bb567o8nit1i

3 Mar 21

Taysha Gene Therapies Reports Full-Year 2020 Financial Results and Provides a Corporate Update

7:15am

8-K

efq u1giznstv

12 Feb 21

Other Events

4:30pm